Gylox Injection contains Glutathione 600mg, a potent antioxidant widely used in clinical settings for its detoxifying and skin-lightening properties. Glutathione is a tripeptide composed of glutamine, cysteine, and glycine, playing a critical role in cellular protection against oxidative stress by neutralizing free radicals and reactive oxygen species. Gylox Injection is indicated for the management of conditions associated with oxidative damage, including liver disorders, neurodegenerative diseases, and certain metabolic syndromes. Additionally, it is employed as an adjuvant therapy in dermatology to improve skin complexion by inhibiting melanin synthesis. The injection is administered intravenously or intramuscularly under medical supervision, ensuring rapid bioavailability and therapeutic efficacy. Dosage and duration of treatment should be tailored according to the patient's clinical condition and response. Common adverse effects are generally mild and may include injection site reactions, gastrointestinal disturbances, or allergic responses. Caution is advised in patients with hypersensitivity to glutathione or its components. Gylox Injection should be used as part of a comprehensive treatment plan, and its administration must be monitored by healthcare professionals to optimize outcomes and minimize potential risks.